13 results
8-K
EX-10.1
SNPX
Synaptogenix Inc
22 Jan 21
Synaptogenix Announces $14.0 Million Private Placement
5:00pm
of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval
8-K
EX-10.1
SNPX
Synaptogenix Inc
16 Jun 21
Synaptogenix Announces $12.5 Million Private Placement
5:09pm
, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale
10-Q
2020 Q3
SNPX
Synaptogenix Inc
23 Dec 20
Quarterly report
5:00pm
be subject to ongoing requirements governing the labeling, packaging, storage, advertising, distribution, promotion, recordkeeping and submission
10-K
2020 FY
SNPX
Synaptogenix Inc
30 Mar 21
Annual report
12:00am
our products. Our products will also be subject to ongoing requirements governing the labeling, packaging, storage, advertising, distribution
424B3
9vhhk whac
30 Apr 21
Prospectus supplement
9:01am
424B1
xvd0ql
12 Nov 20
Prospectus with pricing info
5:24pm
DRS
tzxjh29ll
30 Jul 20
Draft registration statement
12:00am
S-1
mlfopsmh68jg pl
9 Oct 20
IPO registration
5:30pm
- Prev
- 1
- Next